Medios AG

XETRA ILM1.DE

Medios AG Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -18.29 M

Medios AG Net Cash Used For Investing Activities is USD -18.29 M for the year ending December 31, 2023, a 80.25% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Medios AG Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -92.59 M, a -568.44% change year over year.
Medios AG Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD 19.77 M, a 375.24% change year over year.
Medios AG Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -7.18 M, a -392.47% change year over year.
Medios AG Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD 2.46 M, a 218.54% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

XETRA: ILM1.DE

Medios AG

CEO	Mr. Matthias Gaertner
IPO Date	Dec. 28, 2007
Location	Germany
Headquarters	Heidestrasse 9
Employees	1,011
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Biotechnology Eyewear Pharmaceuticals

Description

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Key trends

Past 5 years